Douglas Richard - Jun 7, 2022 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Richard Douglas
Stock symbol
ALDX
Transactions as of
Jun 7, 2022
Transactions value $
$0
Form type
4
Date filed
6/9/2022, 05:06 PM
Previous filing
Dec 15, 2021
Next filing
Jun 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +53.8K $0.00 53.8K Jun 7, 2022 Common Stock 53.8K $3.60 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +13.9K $0.00 13.9K Jun 7, 2022 Common Stock 13.9K $3.60 Direct F2
transaction ALDX Stock Option (Right to Buy) Award $0 +1.62K $0.00 1.62K Jun 7, 2022 Common Stock 1.62K $3.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date.
F3 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.